http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104817542-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K101-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate | 2015-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104817542-B |
| titleOfInvention | A kind of EGFR positive electrons tracer and its preparation method and application |
| abstract | The invention discloses a kind of EGFR positive electrons tracer and its preparation method and application.The structural formula of EGFR positive electron tracers is .The EGFR positive electron tracers of the present invention, tracer effect is good, the most frequently used with current clinic 18 F FDG compare, and the tracer has specificity well, can positive identification skin factor acceptor（EGFR）Height expression tumour.Its preparation method is convenient, simple, quick, and full-automatic production can be achieved, can meet scientific research and clinical demand.In application aspect, 18 F Erlotinib PET imagings can be used not only as the screening of clinical anti-cancer medicine Erlotinib sensitive individuals, and have good application prospect in screening small molecule EGFR inhibitor in detection EGFR expressions and medical industry. |
| priorityDate | 2015-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.